Pharmadax Inc (法德生技藥品) yesterday said it has gained marketing approval in China for its generic schizophrenia drug and expects to grab 20 percent of the market within three years.
On Sunday, the company received approval from the Chinese National Medical Products Administration (NMPA) for the 50mg, 150mg, 200mg, 300mg and 400mg versions of its quetiapine fumarate ER tablets, Pharmadax said, adding that its drug is the generic version of AstraZeneca PLC’s Seroquel XR tablet.
The company obtained US Food and Drug Administration (FDA) approval for the antipsychotic drug in 2017.
The US approval helped the firm secure a priority review with the NMPA, which sped up the licensing process to less than two years, Pharmadax said.
While competition has become heated in the US, with a few companies producing generic versions of Seroquel, including Handa Pharmaceuticals Inc (漢達生技) and India’s Lupin Ltd, Pharmadax said that there would be less competition in China.
“Currently, only the original Seroquel is available in China, and we are the first generic drug company to obtain approval, while other companies are still waiting, so we are confident that we can stay ahead of our rivals,” a company official told the Taipei Times.
Sales of quetiapine fumarate tablets in China increased 32.13 percent year-on-year to 1.75 billion yuan (US$244.9 million) last year, Pharmadax said.
With the Chinese government paying more attention to mental health, more health programs or support services are expected to be launched in the country, which would likely boost sales of antipsychotic drugs, the company said.
Pharmadax has set a target of annual sales growth of 50 percent over the next three years, aided by China-based Coland Holdings Ltd (康聯控股), which is responsible for marketing the drug for the next five years.
Coland has set up distribution channels in more than 200 cities and at more than 3,500 hospitals in China, Pharmadax said.
The company said it would begin marketing the drug in China soon, declining to give an exact date.
Pharmadax has finalized the prices for Quetiapine Fumarate with Coland, which would be slightly lower than the original drug, it said.
The company would produce 800 million tablets per year at its two plants in Foshan, Guangdong Province, it added.
Semiconductor business between Taiwan and the US is a “win-win” model for both sides given the high level of complementarity, the government said yesterday responding to tariff threats from US President Donald Trump. Home to the world’s largest contract chipmaker, Taiwan Semiconductor Manufacturing Co (TSMC, 台積電), Taiwan is a key link in the global technology supply chain for companies such as Apple Inc and Nvidia Corp. Trump said on Monday he plans to impose tariffs on imported chips, pharmaceuticals and steel in an effort to get the producers to make them in the US. “Taiwan and the US semiconductor and other technology industries
A start-up in Mexico is trying to help get a handle on one coastal city’s plastic waste problem by converting it into gasoline, diesel and other fuels. With less than 10 percent of the world’s plastics being recycled, Petgas’ idea is that rather than letting discarded plastic become waste, it can become productive again as fuel. Petgas developed a machine in the port city of Boca del Rio that uses pyrolysis, a thermodynamic process that heats plastics in the absence of oxygen, breaking it down to produce gasoline, diesel, kerosene, paraffin and coke. Petgas chief technology officer Carlos Parraguirre Diaz said that in
CHIP WAR: Tariffs on Taiwanese chips would prompt companies to move their factories, but not necessarily to the US, unleashing a ‘global cross-sector tariff war’ US President Donald Trump would “shoot himself in the foot” if he follows through on his recent pledge to impose higher tariffs on Taiwanese and other foreign semiconductors entering the US, analysts said. Trump’s plans to raise tariffs on chips manufactured in Taiwan to as high as 100 percent would backfire, macroeconomist Henry Wu (吳嘉隆) said. He would “shoot himself in the foot,” Wu said on Saturday, as such economic measures would lead Taiwanese chip suppliers to pass on additional costs to their US clients and consumers, and ultimately cause another wave of inflation. Trump has claimed that Taiwan took up to
SUBSIDIES: The nominee for commerce secretary indicated the Trump administration wants to put its stamp on the plan, but not unravel it entirely US President Donald Trump’s pick to lead the agency in charge of a US$52 billion semiconductor subsidy program declined to give it unqualified support, raising questions about the disbursement of funds to companies like Intel Corp and Taiwan Semiconductor Manufacturing Co (台積電). “I can’t say that I can honor something I haven’t read,” Howard Lutnick, Trump’s nominee for commerce secretary, said of the binding CHIPS and Science Act awards in a confirmation hearing on Wednesday. “To the extent monies have been disbursed, I would commit to rigorously enforcing documents that have been signed by those companies to make sure we get
RSS